Process for annealing amorphous atorvastatin
View Patent ↗Processes for annealing amorphous atorvastatin is described. Pharmaceutical compositions and formulations containing annealed amorphous atorvastatin are also described.
1. A process for annealing amorphous atorvastatin comprising irradiating amorphous atorvastatin with microwave at a frequency ranging from about 1 GHz to about 100 GHz and power of about 1 watt to about 3000 watts either in a continuous or pulse mode for a time period ranging from about 1 second to about 10 hours.
2. The process of claim 1 , wherein said amorphous atorvastatin is irradiated with microwave at a frequency of about 2.45 GHz and power about 10 W to about 500 W in a continuous mode range for a time period of about 10 seconds up to about 10 hours.
3. The process of claim 1 , wherein said amorphous atorvastatin is irradiated from about 1 minute up to about 10 hours with microwave at a frequency of about 2.45 GHz and power about 1 W to about 3000 W in a pulse mode range for a time period of about 10 to about 600 seconds.
4. The process of claim 1 , wherein said amorphous atorvastatin is amorphous atorvastatin calcium.
5. The process of claim 1 , wherein said amorphous atorvastatin is admixed with a pharmaceutically acceptable diluent, carrier, or excipient prior to said irradiating step.
6. A process for annealing amorphous atorvastatin comprising irradiating amorphous atorvastatin with ultrasound at a frequency ranging from about 15 KHz to about 40 KHz and power of about 100 watts to 4000 watts either in a continuous or pulse mode range for a time period ranging from about 1 second to about 10 hours.
7. The process of claim 6 , wherein said amorphous atorvastatin is irradiated with ultrasound at a frequency of about 15 KHz to about 40 KHz and power of about 100 W to 3000 W in a continuous mode range for a time period of about 10 seconds up to about 10 hours.
8. The process of claim 6 , wherein said amorphous atorvastatin is irradiated from about 1 minute up to about 10 hours with ultrasound at a frequency of about 20-35 KHz and power of about 100 W to 3000 W in a pulse mode range for a time period of about 10 to about 600 seconds.
9. The process of claim 6 , wherein said amorphous atorvastatin is amorphous atorvastatin calcium.
10. The process of claim 6 , wherein said amorphous atorvastatin is admixed with a pharmaceutically acceptable diluent, carrier, or excipient prior to said irradiating step.
11. The process of claim 1 , or 6 , wherein said amorphous atorvastatin is treated with a plasticizer prior to or during the annealing process.